Insulin pump is used to deliver insulin in the body in case of patients with diabetes. Insulin delivery is the most important part of the treatment plan for patients with Type 1 and Type 2 diabetes. Diabetes is one of the major health problem whose prevalence is increasing as a rapid pace. Therefore, there is need for early diagnosis and management of the disease to avoid further complications such as heart disease.
The growth of insulin pump market is attributed to the rising prevalence of diabetes, new product launch by market players and growing awareness towards diabetes and insulin delivering devices. Furthermore, extensive research and development activities in diabetes and its related health expenditure is likely to add new opportunities for the market in the coming years.
The “Global Insulin Pump Market Analysis to 2025” is a specialized and in-depth study of the insulin pump industry with a focus on the global market trend. The report aims to provide an overview of global Insulin pump market with detailed market segmentation by product, end user, and geography. The global Insulin pump market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
On the basis of product, the market is segmented into tethered and untethered. On the basis of application, the market is segmented into type I diabetes and type II diabetes.
The report provides a detailed overview on the industry including both qualitative and quantitative information. It provides overview and forecast of the global insulin pump market based on product, and application. It also provides market size and forecast till 2025 for overall Insulin Pump market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
In North America, presence of key market players, use of disposable insulin pumps and rising awareness about diabetes management drives the growth of the market. The US leads the market followed by Canada. Asia Pacific is the fastest growing market due to high prevalence of diabetes and rising geriatric population.
The market is expected to exhibit speedy growth in developing countries of Asia Pacific such as India. The growth of the market is characterized by increasing geriatric population diagnosed with diabetes and rising demand for diabetes management devices in the market. Additionally, growth of medical device industry with launch of new diagnostic and treatment devices also accelerate the growth of the market.
The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
The report also includes the profiles of key insulin pump manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Insulet Corporation, Medtronic, Tandem Diabetes Care, Animas Corporation, Cell Novo, Sooil Development Company, Microport Scientific Corporation, Valeritas, Inc., Roche Diabetes Care Limited, Ypsomed AG and others.
The List of Companies
1. Insulet Corporation
3. Tandem Diabetes Care
4. Animas Corporation
5. Cell Novo
6. Sooil Development Company
7. Microport Scientific Corporation
8. Valeritas, Inc.
9. Roche Diabetes Care Limited
10. Ypsomed AG